ImmuCell Corporation (ICCC) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immucell Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.217 -- 00:00:05.301 Morning and welcome to the INUSA Corporation Report 1st Quarter ended March 00:00:05.301 -- 00:00:11.387 31st, 2025 Audited Financial Results Conference Call. 00:00:11.387 -- 00:00:14.510 All participants will be in listen-only mode. 00:00:14.510 -- 00:00:18.874 After today's presentation, there will be an opportunity to ask questions. 00:00:18.874 -- 00:00:22.697 Please note this event is being recorded. 00:00:22.697 -- 00:00:27.942 I would now like to turn the conference call over to Joe Diaz of Listen Partners. 00:00:27.942 -- 00:00:29.984 Please go ahead. 00:00:29.984 -- 00:00:33.787 Thank you, Vicki. Good morning and welcome to all. 00:00:33.787 -- 00:00:38.431 As the operator indicated, my name is Joe Diaz with Lithum Partners. 00:00:38.431 -- 00:00:42.275 We are the investor relations consulting firm for EmuCell. 00:00:42.275 -- 00:00:47.439 I thank all of you for joining us today to discuss the unaudited financial results for 00:00:47.439 -- 00:00:51.201 the first quarter ended March 31, 2025. 00:00:51.523 -- 00:00:56.467 Listeners are reminded and cautioned that statements made by management during the course 00:00:56.467 -- 00:00:59.515 of this call include forward-looking statements. 00:00:59.515 -- 00:01:04.540 which include any statement that refers to future events or expected 00:01:04.540 -- 00:01:10.606 future results or predictions about steps the company plans to take in the future. 00:01:10.606 -- 00:01:15.852 These statements are not guarantees of performance and are subject to risks and uncertainties 00:01:15.852 -- 00:01:21.617 that could cause actual results, outcomes, or events to differ materially 00:01:21.617 -- 00:01:24.340 from those discussed today. 00:01:24.340 -- 00:01:29.205 Additional information re...